NAPTUMOMAB ESTAFENATOX

UNII: 93T929W6LC
Preferred Substance Name: NAPTUMOMAB ESTAFENATOX

676258-98-3
ABR-217620
ANYARA
ANYARA TTS CD3
IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR-ASSOCIATED ANTIGEN) (MOUSE MONOCLONAL 5T4 HEAVY CHAIN FRAGMENT) FUSION PROTEIN WITH SUPERANTIGEN SEA/E-120 (SYNTHETIC), COMPLEX WITH MOUSE MONOCLONAL 5T4 LIGHT CHAIN
NAPTUMOMAB ESTAFENATOX [INN]
NAPTUMOMAB ESTAFENATOX [MART.]
NAPTUMOMAB ESTAFENATOX [WHO-DD]
SUPERANTIGEN ABR-217620
TTS-CD3

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

NAPTUMOMAB ESTAFENATOX

Synonyms and Mappings

Resources

Note